Military


Armored Multi-Purpose Vehicle (AMPV)

The Armored Multi-Purpose Vehicle (AMPV) family of vehicles is a Modified Capital Asset materiel solution replacement for the M113 family of vehicles to mitigate current and future capability gaps in force protection, mobility, reliability, and interoperability by mission role variant to support the Armored Brigade Combat Team (ABCT) across the Spectrum of Conflict. The AMPV family of vehicles will replace the 5 mission roles currently performed by the M113 family of vehicles by transferring the existing M113 Mission Equipment Packages (MEP) to a new vehicle platform.

As of 2013, the AMPV vehicle fleet would consist of the following 5 variants tailored to specific mission roles within ABCT: Mission Command Vehicle, Medical Treatment Vehicle, Medical Evacuation Vehicle, General Purpose Vehicle, and Mortar Carrier Vehicle. The Mission Command Vehicle platform would enable effective mission command planning and execution for both the Tactical Operations Center and Tactical Command Vehicle subvariants and would host current Battle Command Systems, future replacements, and upgrades of hardware and software. The Medical Treatment Vehicle platform would provide a protected surgical environment with adequate lighting and accessible medical equipment and the capability for immediate medical care for one patient by a medical crew of 4. The Medical Evacuation Vehicle platform would conduct ambulance type activities and provide casualty evacuation for up to 4 litter or 6 ambulatory patients with a crew of 3 medical attendants. The General Purpose Vehicle platform would operate throughout the battle space by conducting re-supply, maintenance, casualty evacuation, and other tasks within the formation. The Mortar Carrier Vehicle platform would provide immediate responsive fire support to conduct fast-paced offensive operations.

The Armored Multi-Purpose Vehicle (AMPV) Program was the proposed Army program for replacement of the M113 Family of Vehicles within the Heavy Brigade Combat Team. Proposed in January 2011, the program was initially put on hold pending an FY12 Materiel Development Decision that would define the program, to be followed by an Analysis of Alternatives that would confirm the system or systems that would replace the M113. The proposed program schedule would see the program achieving Milestone B and entering Engineering and Manufacturing Development by the end of FY13, reaching Milestone C in FY16, having the first prototype vehicles delivered in early FY17, and then seeing the first unit equipped with the selected AMPV design by the end of FY17.

For the AMPV program the Army would look to consider existing or programmed solutions, which might include, but were not limited to, derivatives of the Bradley Fighting Vehicle, Stryker variants, Mine-Resistant Ambush Protected (MRAP) vehicles, variants of the Ground Combat Vehicle (GCV) also in development, or other systems. Even prior to the Materiel Development Decision, a derivative of the Bradley Fighting Vehicle, using the A3 vehicle chassis and body with additional improvements, but without the turret, had been proposed. The AMPV family was expected to include a number of variants, including: general purpose vehicle, command vehicle, mortar carrier vehicle (accommodating a smoothbore 120mm mortar system), and medical treatment and medical evacuation vehicles.

An analysis of alternatives began following the approval of the AMPV requirement for materiel development in February 2012. A total of $74 million had been requested in the FY13 budget to fund both the AMPV analysis of alternatives and pre-milestone A development activities. Initial focus for the AMPV program would be on replacing M113s within the Army Heavy Brigade Combat Teams. The remaining efforts would then focus on a future decision point to address the M113s located in echelons above brigade.

A draft analysis of alternatives report was provided to a team at the US Army Research Laboratory's Survivability/Lethality Analysis Directorate for review in June 2012. The same team had been tasked with conducting the review of the GCV analysis of alternatives. The draft report had been produced by the US Army's Training and Doctrine Command, which drew upon the review conducted to present a final analysis on the replacement of the M113A3 vehicles to Army leadership later in the summer of 2012. The AMPV then became set to go through the Army's typical acquisition process.

On 22 March 2013, the US Army issued a draft request for proposals (RFP) for the AMPV program. The draft RFP stated that the non-cost/price factors, when combined, were significantly more important than the cost/price factor. No proposal, no matter how highly rated under the non-cost/price factors, would be considered for award if unaffordable for either the AMPV Engineering and Manufacturing Development (EMD) phase or the Low Rate Initial Production (LRIP) phase. For EMD, this included affordability based on (a) the total available funding in FY14-FY17 and, (b) since the awards would be RDTE incrementally funded contracts, available RDT&E funding within each of the FY14-FY17 funding periods. For LRIP, this included affordability based on (c) the total available Production funding in FY18-FY20 and, (d) since the option year CLINs would be funded by fiscal year, available Production funding within each of the FY18-FY20 funding periods. According to draft RFP, the availability of funding for the AMPV EMD Phase for FY14-FY17 was: $65.2 Million (FY14), $145.5 Million (FY15), $109.9 Million (FY16), and $67.4 Million (FY17). Also according to the draft RFP, the availability of funding for the AMPV LRIP Phase for FY18-FY20 was: $335.4 Million (FY18), $361.2 Million (FY19), and $378.9 Million (FY20).

During the EMD phase, each of the 5 AMPV vehicle variants were to be configured with existing Mandatory Integration Items (MII) and the vehicles would be developed, designed, modeled, simulated, fabricated, tested, and delivered to maximize performance, within the stated affordability constraints. The purpose of the AMPV EMD Phase was to: complete full system integration, develop an affordable and executable manufacturing process, ensure operational supportability with particular attention to minimizing the logistics footprint, implement human systems integration (HSI), ensure vehicles were designed for producibility, ensure affordability, protect critical program information, and demonstrate system integration, interoperability, safety, and utility. The EMD contract would provide for fabrication, assembly, integration, testing and test support, and related requirements. The selected contractor would deliver 29 prototype vehicles, including all non-vehicle hardware, such as Basic Issue Items (BII), a System Support Package (SSP), Special Tools and Test Equipment, Cold Start Kits, Armor Coupon Sets, Ballistic Hull Structures, and data deliverables.

The draft RFP indicated that a contract award for the EMD phase was anticipated for third quarter of 2014. Included in the award of the EMD contract would also be a 3 option years of LRIP. These options would be separated into 15 different Contractor Line Item Numbers, broken out by variant, for each option year, and placed on contract with not-to-exceed ceiling pricing. In addition, the Government may offer to enter into an exchange agreement with the contractor, to exchange Bradley, M113, M1068, M1064, and M577 vehicles for AMPVs, with these vehicles being referred to as Optional Exchange Vehicles (OEVs). The maximum number of vehicles available for exchange for the EMD portion of the contract was 62. The maximum number of vehicles available for exchange for the first option year of LRIP performance was 114, for the second option year was 214, and for the third option year was 260. The vehicles available would be identified by serial number, and the contractor would have the opportunity to survey the vehicles offered for exchange prior to submitting a proposal. All vehicles were to be offered in as is condition. In exchange for vehicles, offerors would propose an exchange credit, which will be applied to the contract.

The production phase strategy was a sole source award to the winner of the EMD competition. A sole source award would be pursued through a sole source justification under Federal Acquisition Regulations 6.302-1, presuming the Government can determine, through Market Research and other analyses, that additional sources could not meet the Governments needs. At the time of the issue of the draft RPF, the Army expected to procure a total of 2,907 AMPVs in the 5 required variants: 993 Mission Command Vehicles, 217 Medical Treatment Vehicles, 790 Medical Evacuation Vehicles, 522 General Purpose Vehicles, and 386 Mortar Carrier Vehicles.




NEWSLETTER
Join the GlobalSecurity.org mailing list